HPTX Insider Trading Activity and SEC Form 4 Filings
HPTX insider trading summary
No open-market insider purchases or sales of Hyperion Therapeutics Inc (HPTX) have been reported on SEC Form 4 in the past 12 months.
Latest HPTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 17, 2015 | Christine A Nash | SVP & Chief Commercial Officer | Sell | $376K (10,000 @ $37.56) |
| Mar 10, 2015 | Christine A Nash | SVP & Chief Commercial Officer | Sell | $44K (1,450 @ $30.10) |
| Mar 10, 2015 | Christine A Nash | SVP & Chief Commercial Officer | Sell | $351K (10,000 @ $35.08) |
| Mar 9, 2015 | Christine A Nash | SVP & Chief Commercial Officer | Sell | $166K (5,650 @ $29.32) |
| Mar 9, 2015 | Christine A Nash | SVP & Chief Commercial Officer | Sell | $84K (2,800 @ $30.00) |
| Feb 27, 2015 | Bruce Frederick Scharschmidt | SVP & Chief Medical Officer | Sell | $745K (24,996 @ $29.79) |
| Feb 27, 2015 | Bruce Frederick Scharschmidt | SVP & Chief Medical Officer | Sell | $146K (4,804 @ $30.43) |
| Jan 20, 2015 | Christine A Nash | SVP & Chief Commercial Officer | Sell | $61K (2,500 @ $24.36) |
| Jan 20, 2015 | Christine A Nash | SVP & Chief Commercial Officer | Sell | $63K (2,500 @ $25.27) |
| Jul 2, 2014 | Bruce Frederick Scharschmidt | SVP & Chief Medical Officer | Sell | $6K (200 @ $28.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.